Bojke L, Epstein D, Craig D, Rodgers M, Woolacott N, Yang H, Sculpher M. Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis. Rheumatology 2011;50 Suppl 4:iv39-iv47
Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. An international registry of systematic-review protocols. Lancet 2011;377(9760):108-9
Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. Establishing a minimum dataset for prospective registration of systematic reviews: an international consultation. Plos ONE 2011;6(11):e27319
Bowden J, Tierney J, Simmonds M, Copas AJ, Higgins JPT. Individual patient data meta-analysis of time-to-event outcomes: one-stage versus two-stage approaches to estimating the hazard ratio under a random effects model. Research Synthesis Methods 2011 ;2:150-62
Brożek JL, Akl EA, Compalati E, Kreis J, Terracciano L, Fiocchi A, Ueffing E, Andrews J, Alonso-Coello P, Meerpohl JJ, Lang DM, Jaeschke R, Williams Jr JW, Phillips B et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 3 of 3. The GRADE approach to developing recommendations. Allergy 2011;66(5):588-95
Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N. Omalizumab for severe and persistent asthma in children aged 6 to 11 years: A NICE Single Technology Appraisal. Pharmacoeconomics 2011; [In press]
CRD and CHE Technology Assessment Group. Fingolimod for the treatment of relapsing remitting multiple sclerosis. Centre for Reviews and Dissemination/Centre for Health Economics; 2011
Chambers D, Wilson P, Thompson C, Hanbury A, Farley K, Light K. Maximizing the impact of systematic reviews in health care decision making: a systematic scoping review of knowledge-translation resources. Milbank Q 2011;89(1):131-156
Craig D, Fayter D, Stirk L, Crott R. Growth monitoring for short stature: update of a systematic review and economic model. Health Technol Assess 2011;15(11):1-64
Craig D, Rice S, Paton F, Fox, D, Woolacott, N. Retigabine for the adjunctive treatment of adults with partial onset seizures in epilepsy with and without secondary generalisation: a Single Technology Appraisal. Centre for Reviews and Dissemination and Centre for Health Economics, 2011
Craig D, Rice S, Paton F, Fox D, Woolacott N. Retigabine for the adjunctive treatment of adults with partial onset seizures in epilepsy with and without secondary generalisation: a NICE Single Technology Appraisal. PharmacoEconomics 2011;[In press]
Erdelyi DJ, Elliott M, Phillips B. Urine catecholamines in paediatrics. Arch Dis Child Educ Pract Ed 2011;96(3):107-11
Gibson M, Petticrew M, Bambra C, Sowden A, Wright K, Whitehead M. Housing and health inequalities: a synthesis of systematic reviews of interventions aimed at different pathways linking housing and health. Health & Place 2011;17(1):175-84. doi:10.1016/j.healthplace.2010.09.011
Golder S, Loke YK, Bland M. Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Med 2011;8(5)
Heirs M, Suekarran S, Slack R, Light K, Gibson F, Glaser A, Hawkins M, Phillips B. A systematic review of models of care for the follow up of childhood cancer survivors. Pediatr Blood Cancer 2011; [In press]
Hempel S, Rubenstein LV, Roberta M Shanman RM, Robbie Foy R, Golder S, Danz M, Shekelle PG. Identifying quality improvement intervention publications - A comparison of electronic search strategies. Implement Sci 201; 6:85
Huat See B, Torgerson C, Gorard S, Ainsworth H, Low G, Wright K. Factors that promote high post-16 participation of some minority ethnic groups in England: a systematic review of the UK-based literature. Research in Post-Compulsory Education 2011;16(1):85-100
James RM, McGuire W, Smith DP. The investigation of infants born to RhD negative mothers: can we safely omit the umbilical cord blood direct antiglobulin test? Arch Dis Child Fetal Neonatal Ed 2011; 96(4):F301-4
Loke YK, Golder S, Vandenbroucke JP. Comprehensive evaluations of the adverse effects of drugs: importance of appropriate study selection and data sources. Therapeutic Advances Drug Safety 2011;2(2):59-68
Maund E, McDaid C, Rice S, Wright K, Jenkins B, Woolacott N. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side-effects after major surgery: a systematic review. Br J Anaesth 2011;106(3):292-7
Meader N, Mitchell AJ, Chew-Graham C, Goldberg D, Rizzo M, Bird V, Kessler, D, Packham J, Haddad M, Pilling S. Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies. Br J Gen Prac 2011;61(593): e808-20
Meyer S, McGuire W, Gottschling S, Mohammed Shamdeen G, Gortner L. The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: Review of the literature. Wien Med Wochenschr 2011;161(7-8):192-203
Morgan JA, Young L, McCormick FM, McGuire W. Promoting growth for preterm infants following hospital discharge. Arch Dis Child Fetal Neonatal Ed 2011;[Epub ahead of print]
Morgan J, Young L, McGuire W. Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev 2011;3:CD001970
Morgan JA, Young L, McGuire W. Pathogenesis and prevention of necrotizing enterocolitis. Curr Opin Infect Dis 2011;24(3):183-9
Morgan J, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev 2011;3:CD001241
Norman G, Rice S, Spackman E, Stirk L, Danso-Appiah A, Suh D, Palmer S, Eastwood A. Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. Health Technol Assess 2011;15(Suppl 1):33-43.
Phillips B, Richards M, Boys R, Hodgkin M, Kinsey S. A home based maintenance therapy programme for acute lymphoblastic leukaemia - practical and safe? J Ped Hematol Oncol 2011; 33(6):433-6
Phillips B, Wade R, Westwood M, Riley R, Sutton AJ. Systematic review and meta-analysis of the value of clinical features to exclude radiographic pneumonia in febrile neutropenic episodes in children and young people. J Paediatr Child Health 2011; [Epub ahead of print]
Rodgers M, Epstein D, Bojke L, Yang H, Craig D, Fonseca T, Myers L, Bruce I, Chalmers R, Sutton A, Sculpher M, Woolacott N. Etanercept, Infliximab and Adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technol Assess 2011;15(10):1-329
Rodgers M, Soares M, Epstein D, Yang H, Fox D, Eastwood A. Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer. Health Technol Assess. 2011;15(Suppl 1):1-12
Simmonds MC, Tierney J, Bowden J, Higgins JPT. Meta-analysis of time-to-event data: a comparison of two-stage methods. Research Synthesis Methods 2011; 2:139-49
Song F, Xiong T, Parekh-Bhurke S, Loke YK, Sutton AJ, Eastwood AJ, Holland R, Chen YF, Glenny AM, Deeks JJ, Altman DG. Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ 2011;343:d4909
Spackman E, Burch J, Faria R, Corbacho B, Fox D, Woolacott N. Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: Evidence Review Group Report. Centre for Reviews and Dissemination and Centre for Health Economics; 2011
Sung L, Manji A, Beyene J, Dupuis L, Alexander S, Phillips R, Lehrnbecher T. Fluoroquinolones in pediatric fever and neutropenia – a systematic review of prospective trials. Pediatr Infect Dis J 2011; 31(5):431-35
Sung L, Phillips R, Lehrnbecher T. Time for paediatric febrile neutropenia guidelines - children are not little adults. Eur J Cancer 2011;47(6):811-3
Vasudevan C, McGuire W. Early removal versus expectant management of central venous catheters in neonates with bloodstream infection. Cochrane Database Syst Rev 2011;(8):CD008436
Walker S, Burch J, McKenna C, Wright K, Griffin S, Woolacott N. Omalizumab for the treatment of severe persistent allergic asthma in children aged 6–11 years. Single Technology Appraisals: A supplement to Health Technology Assessment Journal 2011;15(Suppl. 1):13-21
Wright K, McDaid C. Reporting of article retractions in bibliographic databases and online journals. J Med Libr Assoc 2011;99(2):164-7
Yang H, Epstein D, Bojke L, Craig D, Light K, Bruce I, Sculpher M, Woolacott N. Golimumab for the treatment of psoriatic arthritis. Health Technol Assess 2011;15(Supp 1):87-96